DPZ three-lens brief
Evidence-based stock research on DPZ. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 26.6pp over 30 days. · Trading at 1% of its 52-week range — deep in the lower band.
- Trading at 1% of its 52-week range — deep in the lower band.
- RSI at 29 — technically oversold.
- Underperforming SPY by 26.6pp over 30 days.
- Analyst mean target $413.29 — 33% above current (31 analysts).
DPZ closed at $311.00 (+0.27%) as of 2026-05-13. Market cap: $10.34B. P/E (trailing) 17.9. Positives: analyst mean target $413.29 — 33% above current (31 analysts).. Concerns: trading at 1% of its 52-week range — deep in the lower band.; rSI at 29 — technically oversold.. Last quarter: Revenue $1.15B, net income $139.81M, free cash flow $524.71M.
Why three lenses on DPZ, not one.
A single reasoning model has blind spots it doesn’t know about. We examine DPZacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/DPZ" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath DPZ brief"></iframe>